Prolynx

Innovative drug delivery system using pre-programmed linkers for controlled release

placeSan Francisco, California, United States calendar_todayFounded 2009 groups8 employees language prolynxinc.com

Registered entities

Innovation

28 patent families (12 granted) — focus: Human necessities, Physics & computing, Operations & transport, Chemistry & metallurgy; filing pace steady. Cited 1,014 times.

YearFilings
20157
20168
20174
20186
20196
20206
20218
202210
20236
20247
20258
20267

Social engagement

Social engagement: 2.9K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include 5AM Ventures, Orbimed, Monograph.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%

Recent activity

5 Jun 2026
Event
ADA TV Film Series 2026
Coming soon